These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats. McCaughran JA; Corcoran ME; Wada JA Pharmacol Biochem Behav; 1974; 2(2):227-33. PubMed ID: 4829599 [No Abstract] [Full Text] [Related]
5. The augmentation of physostigmine toxicity in the rat by 9 -tetrahydrocannabinol. Rosenblatt JE; Janowsky DS; Davis JM; el-Yousef MK Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):479-82. PubMed ID: 5034509 [No Abstract] [Full Text] [Related]
6. [Toxicity of Indian hemp]. Nahas GG; Vourch G Nouv Presse Med; 1973 Jan; 2(3):167-73. PubMed ID: 4685021 [No Abstract] [Full Text] [Related]
7. Distribution studies of (14C)delta-9-tetrahydrocannabinol in mice: effect of vehicle, route of administration, and duration of treatment. Mantilla-Plata B; Harbison RD Toxicol Appl Pharmacol; 1975 Nov; 34(2):292-300. PubMed ID: 1209626 [No Abstract] [Full Text] [Related]
8. Oral and intravenous toxicity of delta9-tetrahydrocannabinol in rhesus monkeys. Thompson GR; Fleischman RW; Rosenkrantz H; Braude MC Toxicol Appl Pharmacol; 1974 Mar; 27(3):648-65. PubMed ID: 4212215 [No Abstract] [Full Text] [Related]
9. General and behavioral pharmacology. Harris LS Pharmacol Rev; 1971 Dec; 23(4):285-94. PubMed ID: 4943947 [No Abstract] [Full Text] [Related]
10. Inhibition of normal growth by chronic administration of delta-9-tetrahydrocannabinol. Manning FJ; McDonough JH; Elsmore TF; Saller C; Sodetz FJ Science; 1971 Oct; 174(4007):424-6. PubMed ID: 5111999 [TBL] [Abstract][Full Text] [Related]
11. Distribution of tritium labelled delta 1-tetrahydrocannabinol in the rat brain following intraperitoneal administration. Layman JM; Milton AS Br J Pharmacol; 1971 Jun; 42(2):308-10. PubMed ID: 5091165 [TBL] [Abstract][Full Text] [Related]
12. Distribution and metabolism in vivo of 14C-tetrahydrocannabinol in the rat. Willinsky MD; Kalant H; Meresz O; Endrenyi L; Woo N Eur J Pharmacol; 1974 Jun; 27(1):106-19. PubMed ID: 4851409 [No Abstract] [Full Text] [Related]
13. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol. McCallum ND; Yagen B; Levy S; Mechoulam R Experientia; 1975 May; 31(5):520-1. PubMed ID: 1140243 [No Abstract] [Full Text] [Related]
14. Reduction of predatory aggression of rats following administration of delta-9-tetrahydrocannabinol. McDonough JH; Manning FJ; Elsmore TF Life Sci I; 1972 Feb; 11(3):103-11. PubMed ID: 4675887 [No Abstract] [Full Text] [Related]
15. Inhalation, parenteral and oral LD50 values of delta 9-tetrahydrocannabinol in Fischer rats. Rosenkrantz H; Heyman IA; Braude MC Toxicol Appl Pharmacol; 1974 Apr; 28(1):18-27. PubMed ID: 4852457 [No Abstract] [Full Text] [Related]
16. Comparison among four vehicles and four routes for administering delta9-tetrahydrocannabinol. Sofia RD; Kubena RK; Barry H J Pharm Sci; 1974 Jun; 63(6):939-41. PubMed ID: 4851104 [No Abstract] [Full Text] [Related]
18. Effects of delta-9-tetrahydrocannabinol on cyclopropane MAC in the rat. Vitez TS; Way WL; Miller RD; Eger EI Anesthesiology; 1973 Jun; 38(6):525-7. PubMed ID: 4706748 [No Abstract] [Full Text] [Related]